PSA Doubling Time Calculator

This PSA doubling time calculator estimates how many months it takes your PSA to double, from two readings and the time between them. It is built for men tracking a rising PSA after prostatectomy, radiation, or during monitoring, where the speed of the rise matters more than any single number. You will get a doubling time in months, a plain-language risk band, and the questions to raise with your urologist. Start with the prostate health hub for the full picture.

Medically reviewed by

Dr. Muhammad Khalid

MBBS, FCPS (Urology), MCPS (Gen. Surgery), CHPE, CRSM · IMC #539472

Last updated

June 28, 2026

Evidence-BasedAUA + EAU biochemical-recurrence thresholds

Used WorldwideThe standard PSA kinetics measure

PrivateNothing is stored or sent

PSA doubling time calculator showing a rising PSA trend line

The Tool

Related Prostate Tools

Calculator PSA Velocity Tracker Tracks how fast your PSA rises in ng/mL per year. Open Tool → Calculator PSA Age-Adjusted Interpreter Shows what a single PSA means for a man your age. Open Tool → Calculator Prostate Cancer Risk Calculator Estimates your risk band before a biopsy decision. Open Tool → Decision Tool Gleason Score Risk Interpreter Turns your Gleason grade into a risk-group picture. Open Tool → Calculator Prostate Volume Calculator Estimates prostate size and PSA density from imaging. Open Tool → Likert IPSS Prostate Symptom Score Scores urinary symptoms with the validated IPSS. Open Tool →

Full Clinical Guide

In This Guide:

Key Takeaways

PSA doubling time is the number of months it takes your PSA to double – the speed of the rise, not its size.
A doubling time under 3 months is the most concerning pattern; over 12 months is the reassuring one.
Both the AUA and EAU treat a doubling time of 9 months or less as higher-risk recurrence after treatment.
Two readings give a rough estimate; three or more values over the past year make it reliable.

What the PSA Doubling Time Calculator Measures

The PSA doubling time calculator tells you how many months it takes your prostate-specific antigen (PSA) to double in value. It is a measure of speed, not size: two men can both sit at a PSA of 1.0 ng/mL, but the one whose level reached 1.0 in three months is in a very different position from the one who took three years to get there. The calculation assumes PSA rises exponentially when disease is active, so it takes the natural logarithm of your two readings and divides the natural log of 2 by the slope between them – the same log-linear method used in the widely cited Memorial Sloan Kettering calculator [1]. It is most useful for men with a rising PSA after surgery or radiation, where doubling time guides what happens next. If you want the related rate measure in ng/mL per year, the PSA Velocity Tracker covers that.

The Physiology: Why Speed Beats the Single Number

Prostate cancer cells, when present and active, tend to grow at a roughly constant rate – which means the PSA they shed climbs along an exponential curve rather than a straight line. Think of it like compound interest: a balance growing at a high rate doubles quickly and keeps accelerating, while a low rate barely moves over years. Doubling time captures that growth rate in a single, intuitive figure. A short doubling time means the underlying biology is moving fast; a long one means it is moving slowly, regardless of how high or low the actual PSA happens to be today. This is why a urologist will often care more about how your PSA is changing than about any one result. After treatment, this distinction separates men who can be safely watched from those who need imaging and a faster decision.

Doubling time turns a row of PSA numbers into a single answer to the only question that matters after treatment: how fast is this moving?

How to Interpret Your Result

The tool sorts your result into three bands. A doubling time under 3 months is the pattern most strongly tied to prostate-cancer-specific death after biochemical recurrence, and it calls for prompt specialist review [2]. A doubling time of 3 to 12 months is the intermediate band that guidelines watch closely – both the American Urological Association and the European Association of Urology classify a doubling time of 9 months or less as higher-risk recurrence [3]. A doubling time over 12 months is the reassuring band: the EAU regards this (with a favorable Gleason grade) as low-risk recurrence where observation is reasonable [4]. Doubling time is read alongside your Gleason grade, not in isolation, so it is worth viewing it next to your Gleason risk group.

What to Do With Your Result

The single most important step is to recalculate with more data before acting on a fast result. Two readings can mislead – a stray high value, a different lab, or a recent infection can fake a short doubling time. The consensus methodology asks for at least three PSA values spread over three months or more, taken at least four weeks apart and from the same assay [5]. If your result lands in the rapid band, ask your urologist about a PSMA PET scan and a faster appointment. In the intermediate band, the conversation is about closer monitoring and whether imaging is warranted now. In the slow band, the question is simply how often to repeat the test. Doubling time was historically used as an active-surveillance trigger, but current practice leans on repeat biopsy and MRI instead – if surveillance is your situation, the active surveillance guide explains the modern approach, and the PSA Interpreter helps place each individual reading in context. If you are unsure about your result, the PDF report this tool generates gives you a ready-made framework to bring to your next appointment.

In My Practice

I see two recurring mistakes with doubling time. The first is acting on two readings alone – a man arrives convinced his cancer is racing back because two numbers doubled in two months, when a third value from his own records flattens the curve completely. The second is the opposite: dismissing a slow but steady climb because no single reading looks alarming. Both errors come from looking at numbers instead of the rate.

Bring every PSA result you have, with dates. The doubling time is only as good as the history you feed it, and your own old lab slips are often the most valuable thing in the room.

References

Memorial Sloan Kettering Cancer Center. PSA Doubling Time nomogram (log-linear calculation method). MSKCC. The calculation standard this tool follows.
Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433-439. DOI. A PSADT under 3 months carried the highest cancer-specific mortality.
American Urological Association / SUO. Advanced Prostate Cancer Guideline (PSADT of 9 months or less defines higher-risk biochemical recurrence). AUA.
European Association of Urology. Guidelines on Prostate Cancer (low-risk biochemical recurrence: PSADT over 12 months with favorable Gleason; observation reasonable). EAU.
Prostate-Specific Antigen Best Practice / PSA Working Group consensus on PSADT calculation (minimum three values over three months, at least four weeks apart, same assay). PMC.

Frequently Asked Questions

What counts as a fast or dangerous PSA doubling time?

A doubling time under 3 months is the fastest, most concerning band, because it is the pattern most strongly linked to cancer progression after treatment. Between 3 and 12 months is intermediate, with 9 months or less flagged by guidelines as higher-risk. Over 12 months is slow and usually reassuring. Speed always matters more than your single PSA number, which the PSA Velocity Tracker measures a different way.

Can I trust a doubling time from just two PSA readings?

Two readings give a useful estimate, but they can be thrown off by a lab change, a recent infection, or one unusual value. A single odd result can fake a fast doubling time. The accepted method uses at least three PSA values over three or more months, taken four weeks or more apart and from the same lab. Treat a two-point result as a screening figure to confirm, not a final answer.

My PSA went down – why does the tool say “not rising”?

A doubling time only exists when PSA is climbing. If your most recent value is the same as or lower than the earlier one, there is nothing doubling, so the tool reports “not rising” rather than a number. That is generally a good sign. A falling or stable PSA after treatment is reassuring, and the post-prostatectomy follow-up guide explains what target levels look like.

How accurate is this tool, and can I rely on it?

This calculator uses the standard log-linear formula that clinical calculators rely on, so the math is sound. But it is only as accurate as the values you enter, and a two-point estimate is inherently rougher than one built from several readings. It is a screening aid to help you understand your trend and prepare for your appointment – not a diagnosis and not a substitute for your urologist’s assessment of your full history.

How do I use this result at my doctor’s appointment?

Tap Download My Report to generate a two-page PDF with your doubling time, the two readings you entered, a plain-language interpretation, and a short list of questions to ask. Bring it to your urologist along with every prior PSA result and its date. The most valuable thing you can add is your own older lab slips, which let the doubling time be recalculated from your full history rather than just two points.

Dr. Muhammad Khalid

MBBS · FCPS (Urology) · MCPS (Gen. Surgery) · CHPE · CRSM · IMC #539472

Specialist urologist with 11+ years of clinical experience across tertiary teaching hospitals. Trained at Lady Reading Hospital and Khyber Teaching Hospital, Peshawar. Author of 5 peer-reviewed international publications in Cureus, WJSA, and AJBS. Procedural expertise: URS, PCNL, RIRS, TURP, TURBT, and major open urological surgery. Full profile →

This article is for educational purposes only and does not constitute medical advice. Always consult your physician or urologist for diagnosis and treatment decisions specific to your condition.